Labcorp Drug Development Engager | Digital Event

Advances in Precision Medicine Approaches for Neurodegenerative Disease

This Engager ran on Thursday November 18, 2021 | 11:00am ET | 8:00am PT

Advances in Precision Medicine Approaches for Neurodegenerative Disease

Welcome to the Labcorp Drug Development Engager, an invitation-only event focused on the role of precision medicine in enabling important discoveries that bring new diagnostics and life-changing therapies to patients suffering neurodegenerative diseases.

This Engager has been created as an exclusive event to provide C-level Executives, Directors, and Heads of Biomarkers, Neurological disorders, and cell and gene therapy in biopharma with the opportunity to delve deep into the challenges and solutions in bringing effective diagnostic and therapeutic to market for complex neurodegenerative diseases.


LabcorpDD_Logo_200x200 (003)

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With more than 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14.0 billion in FY2020. Learn about Labcorp Drug Development at, or follow us on LinkedIn and Twitter @Labcorp.